( in Million)
Particulars
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
175.6
319.7
92.4
1672.8
Total Expenditure
700.3
869.9
644.2
1926.8
PBIDT (Excl OI)
-524.7
-550.2
-551.8
-254
Other Income
155
86.4
462
184.9
Operating Profit
-369.7
-463.8
-89.80
-69.09
Exceptional Items
NA
NA
NA
NA
PBDT
-388.2
-503.3
-111
-111.4
Depreciation
65.1
60.9
55
39.7
Profit Before Tax
-453.3
-564.2
-166
-151.1
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-481.6
-467.6
-180.7
-324.3
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
-481.6
-467.6
-180.7
-324.3
Minority Interest
-0.1
-0.2
-0.1
-0.2
Shares of Associates
960.7
980.2
1031.6
99.6
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
479
512.4
850.8
-224.9
Equity Capital
2132.8
2132.6
1550.9
1550.9
Face Value (IN RS)
10
10
10
10
Calculated EPS
2.24
2.40
5.48
-1.45
Calculated EPS (Annualised)
8.98
9.61
21.94
-5.80
No of Public Share Holdings
101472490
101449995
75768210
75766468
% of Public Share Holdings
47.58
47.57
48.86
48.85
PBIDTM% (Excl OI)
-298.80
-172.09
-597.18
-15.18
PBIDTM%
-210.53
-145.07
-97.18
-4.13
PBDTM%
-221.07
-157.42
-120.12
-6.65
PBTM%
-258.14
-176.47
-179.65
-9.03
PATM%
-274.25
-146.26
-195.56
-19.38